Abstract 816: Spatial metabolic gradients drive epigenetic reprogramming in human glioblastoma.
Abstract Human glioblastoma (GBM) contains sharp spatial transitions in oxygen tension, metabolism, and lineage organization, yet how these microenvironmental cues become epigenetically encoded at the chromatin level remains poorly understood. Using cyclic immunofluorescence (CyCIF) on human IDH-wildtype GBM specimens enriched for necrosis, we mapped tumor cell lineages and histone H3K18 lactylation (H3K18la) at single-cell resolution. Necrotic and hypoxic regions displayed distinct lineage organization and elevated H3K18la, consistent with increased glycolytic flux and lactate accumulation under oxygen deprivation. In patient-derived GBM cell lines, hypoxia-mimetic treatment with deferoxamine (DFX) recapitulated this epigenetic response. RNA-sequencing and CUT&RUN profiling revealed that H3K18la associates with activation of hypoxia and epithelial-to-mesenchymal transition-related transcriptional programs, along with repression of cell-cycle and mitotic regulators. Together, these findings demonstrate how spatial metabolic gradients shape chromatin states and transcriptional networks in GBM, highlighting lactylation as a mechanism by which microenvironmental stress becomes epigenetically encoded and manifested as lineage-specific transcriptional adaptation. Citation Format: Sankha Subhra Chakrabarty, Yilin Xu, Shannon Coy, Jia-Ren Lin, Dimitrius Tansini Pramio, Pilar Baldominos, Clement Bodineau, Nathalie Y. Agar, Judith Agudo, Marcos Simoes-Costa, Keith L. Ligon, Peter Karl Sorger, Sandro Santagata. Spatial metabolic gradients drive epigenetic reprogramming in human glioblastoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 816.
Authors
- Sandro Santagata (ORCID: https://orcid.org/0000-0002-7528-9668)
- Keith L. Ligon (ORCID: https://orcid.org/0000-0002-7733-600X)
- Dimitrius T. Pramio (ORCID: https://orcid.org/0000-0002-4517-7163)
- Pilar Baldominos (ORCID: https://orcid.org/0000-0002-4988-6290)
- Nathalie Y.R. Agar (ORCID: https://orcid.org/0000-0003-3149-3146)
- Sankha Subhra Chakrabarty (ORCID: https://orcid.org/0000-0003-0004-2254)
- Clément Bodineau (ORCID: https://orcid.org/0000-0002-0532-8852)
- Shannon Coy (ORCID: https://orcid.org/0000-0003-0033-9031)
- Marcos Simões-Costa (ORCID: https://orcid.org/0000-0003-1452-7068)
- Jia-Ren Lin
- Judith Agudo
- Yilin Xu
- Peter Karl Sorger
Institutions
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- Harvard University (US)
- Dana-Farber Cancer Institute (US)
Publication Details
- Journal
- Cancer Research
- Published
- 2026-04-03
- DOI
- https://doi.org/10.1158/1538-7445.am2026-816
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00